These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33333045)

  • 1. Advances in drugs of abuse testing.
    Tamama K
    Clin Chim Acta; 2021 Mar; 514():40-47. PubMed ID: 33333045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the validity of gas chromatography- mass spectrometry and liquid chromatography- tandem mass spectrometry analysis of urine samples for morphine, codeine, 6-acetylmorphine, and benzoylecgonine.
    Stout PR; Bynum ND; Mitchell JM; Baylor MR; Ropero-Miller JD
    J Anal Toxicol; 2009 Oct; 33(8):398-408. PubMed ID: 19874645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine Multi-drug Screening with GC-MS or LC-MS-MS Using SALLE-hybrid PPT/SPE.
    Lee J; Park J; Go A; Moon H; Kim S; Jung S; Jeong W; Chung H
    J Anal Toxicol; 2018 Nov; 42(9):617-624. PubMed ID: 29762685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous detection of 19 drugs of abuse on dried urine spot by liquid chromatography-tandem mass spectrometry.
    Lee Y; Lai KKY; Sadrzadeh SMH
    Clin Biochem; 2013 Aug; 46(12):1118-1124. PubMed ID: 23583348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power of Orbitrap-based LC-high resolution-MS/MS for comprehensive drug testing in urine with or without conjugate cleavage or using dried urine spots after on-spot cleavage in comparison to established LC-MS
    Michely JA; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):158-163. PubMed ID: 28755512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS-MS vs ELISA: Validation of a Comprehensive Urine Toxicology Screen by LC-MS-MS and a Comparison of 100 Forensic Specimens.
    Kahl KW; Seither JZ; Reidy LJ
    J Anal Toxicol; 2019 Oct; 43(9):734-745. PubMed ID: 31424082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening.
    Lynch KL; Breaud AR; Vandenberghe H; Wu AH; Clarke W
    Clin Chim Acta; 2010 Oct; 411(19-20):1474-81. PubMed ID: 20540936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the validity of gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry analysis of urine samples II: amphetamine, methamphetamine, (±)-3,4-methylenedioxyamphetamine, (±)-3,4-methylenedioxymethamphetamine, (±)-3,4-methylenedioxyethylamphetamine, phencyclidine, and (±)-11-nor-9-carboxy-Δ⁹-tetrahydrocannabinol.
    Stout PR; Bynum ND; Lewallen CM; Mitchell JM; Baylor MR; Ropero-Miller JD
    J Anal Toxicol; 2010 Oct; 34(8):430-43. PubMed ID: 21819787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.
    Fels H; Dame T; Sachs H; Musshoff F
    Drug Test Anal; 2017 May; 9(5):824-830. PubMed ID: 27373549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary screening for methylphenidate (Ritalin) abuse: a comparison of liquid chromatography-tandem mass spectrometry, gas chromatography-mass spectrometry, and immunoassay methods.
    Eichhorst J; Etter M; Lepage J; Lehotay DC
    Clin Biochem; 2004 Mar; 37(3):175-83. PubMed ID: 14972638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of gamma-hydroxybutyrate in hair: validation of GC-MS and LC-MS/MS methods and application to a real case.
    Bertol E; Argo A; Procaccianti P; Vaiano F; Di Milia MG; Furlanetto S; Mari F
    J Pharm Biomed Anal; 2012 Nov; 70():518-22. PubMed ID: 22884787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postmortem drug screening by non-targeted and targeted ultra-performance liquid chromatography-mass spectrometry technology.
    Rosano TG; Wood M; Swift TA
    J Anal Toxicol; 2011 Sep; 35(7):411-23. PubMed ID: 21871149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid characterization of drugs in a single hair using thermal desorption ionization mass spectrometry.
    Kong R; Li L; Liu W; Xiang P; Zhao J
    Anal Methods; 2022 Feb; 14(8):806-812. PubMed ID: 35138309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS).
    Broecker S; Herre S; Pragst F
    Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of urine and hair testing for drugs of abuse in the control of abstinence in driver's license re-granting.
    Dufaux B; Agius R; Nadulski T; Kahl HG
    Drug Test Anal; 2012 Jun; 4(6):415-9. PubMed ID: 22447399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.